Laurion Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Laurion Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,300	Closed	-$1.02M	–	1256
2020 Q2	$1.02M	Buy	+8,300	New	+$942K	0.01%	445
2019 Q4	–	Sell	-15,400	Closed	-$1.77M	–	1339
2019 Q3	$1.77M	Buy	+15,400	New	+$2.34M	0.01%	527
2017 Q2	–	Sell	-6,200	Closed	-$750K	–	1973
2017 Q1	$750K	Buy	+6,200	New	+$761K	0.01%	812
2014 Q3	–	Sell	-40,100	Closed	-$4.3M	–	415
2014 Q2	$4.3M	Buy	+40,100	New	+$2.79M	0.09%	175

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Laurion Capital Management's GWPH Position: Q3 2020 in Review

Laurion Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 8,300 shares — an estimated $1.02M sold.

Laurion Capital Management first reported a position in GWPH in Q2 2014 and held it in 4 quarters. The position peaked at $4.3M in Q2 2014. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

Laurion Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Laurion Capital Management sold 8,300 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $1.02M.
Laurion Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 4 quarters.
Laurion Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4.3M in Q2 2014.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.